Chinese herbal medicine (“3 medicines and 3 formulations”) for COVID ‐19: rapid systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Chinese herbal medicine (“3 medicines and 3 formulations”) for COVID ‐19: rapid systematic review and meta‐analysis

Published:2021-09-16 Issue:1 Volume:28 Page:13-32
ISSN:1356-1294
Container-title:Journal of Evaluation in Clinical Practice
language:en
Short-container-title:Evaluation Clinical Practice

Author:

Wang Yangzihan¹^ORCID,Greenhalgh Trisha²^ORCID,Wardle Jon³^ORCID,

Affiliation:

1. Population Health Science Institute Newcastle University Newcastle upon Tyne UK

2. The Nuffield Department of Primary Care Health Sciences University of Oxford Oxford UK

3. National Centre for Naturopathic Medicine Southern Cross University Lismore New South Wales Australia

Funder

NIHR School for Primary Care Research

Wellcome Trust

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jep.13614

Reference51 articles.

1. China NHCotPsRo. The diagnosis and treatment plan for pneumonia caused by novel Coronavirus Beijing China ADD.2020.

2. BaiJ.The epidemic can only be relieved after 90% of Hong Kong population get infected. Experts: impossible. China News.2020.

3. Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19

4. Herbal medicine for the management of COVID‐19 during the medical observation period: a review of guidelines;Ang L;Integr Med Res,2020

5. Natural herbal medicine Lianhuaqingwen capsule anti‐influenza a (H1N1) trial: a randomized, double blind, positive controlled clinical trial;Duan ZP;Chin Med J (Engl),2011

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network-based pharmacology and UHPLC-Q-Exactive-Orbitrap-MS reveal Jinhua Qinggan granule's mechanism in reducing cellular inflammation in COVID-19;Frontiers in Immunology;2024-07-04

2. Efficacy of Shen Cao Gan Jiang Tang on Non-severe COVID-19 Patients: A Multicenter, Randomized, Open-Label Clinical Trial;Cureus;2024-06-14

3. Protective effects of Jing-Si-herbal-tea in inflammatory cytokines-induced cell injury on normal human lung fibroblast via multiomic platform analysis;Tzu Chi Medical Journal;2024-03-26

4. Effect and mechanism of quercetin or quercetin‐containing formulas against COVID‐19: From bench to bedside;Phytotherapy Research;2024-03-13

5. Drugs and natural products for the treatment of COVID-19 during 2020, the first year of the pandemic;Boletín Médico del Hospital Infantil de México;2024-03-12